Targeting Risk Factors for Diabetes in Subjects With Normal Blood Cholesterol Using Omega-3 Fatty Acids

Clinical trial NCT04485871 · RECRUITING

Trial details

NCT number: NCT04485871
Sponsor: Institut de Recherches Cliniques de Montreal
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Type 2 Diabetes Inflammation Insulin Sensitivity/Resistance Fatty Acids, Omega-3

Start date: 2019-12-19
Primary completion: 2027-05-31
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.